Karin von Schwarzenberg

7.0k total citations
24 papers, 890 citations indexed

About

Karin von Schwarzenberg is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Karin von Schwarzenberg has authored 24 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Karin von Schwarzenberg's work include ATP Synthase and ATPases Research (9 papers), Ubiquitin and proteasome pathways (5 papers) and Mitochondrial Function and Pathology (4 papers). Karin von Schwarzenberg is often cited by papers focused on ATP Synthase and ATPases Research (9 papers), Ubiquitin and proteasome pathways (5 papers) and Mitochondrial Function and Pathology (4 papers). Karin von Schwarzenberg collaborates with scholars based in Germany, Switzerland and Italy. Karin von Schwarzenberg's co-authors include Angelika M. Vollmar, Peter Brossart, Rolf Müller, Katharina M. Brauer, Frank Grünebach, Ernst Wagner, Rebekka Kubisch, Alberto Ballestrero, Dirk Trauner and Alessio Nencioni and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Karin von Schwarzenberg

24 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin von Schwarzenberg Germany 15 572 158 143 134 125 24 890
Li-Yuan Bai Taiwan 17 466 0.8× 102 0.6× 68 0.5× 150 1.1× 99 0.8× 42 869
Carmen Aanei France 12 484 0.8× 151 1.0× 185 1.3× 219 1.6× 205 1.6× 22 979
Yuyin Li China 21 617 1.1× 132 0.8× 173 1.2× 284 2.1× 119 1.0× 50 984
Ayse Batova United States 18 603 1.1× 81 0.5× 70 0.5× 232 1.7× 174 1.4× 28 995
Fusako Nishigaki Japan 19 469 0.8× 141 0.9× 73 0.5× 183 1.4× 120 1.0× 41 1.0k
Shie-Pon Tzung United States 11 490 0.9× 142 0.9× 65 0.5× 159 1.2× 60 0.5× 12 730
Xavier Billot Canada 7 463 0.8× 79 0.5× 57 0.4× 152 1.1× 55 0.4× 10 769
Randall Evans United States 13 609 1.1× 117 0.7× 91 0.6× 220 1.6× 132 1.1× 24 991
Xianping Shi China 20 683 1.2× 71 0.4× 154 1.1× 261 1.9× 148 1.2× 35 1.0k
Haolan Wang China 6 520 0.9× 86 0.5× 61 0.4× 251 1.9× 192 1.5× 9 861

Countries citing papers authored by Karin von Schwarzenberg

Since Specialization
Citations

This map shows the geographic impact of Karin von Schwarzenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin von Schwarzenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin von Schwarzenberg more than expected).

Fields of papers citing papers by Karin von Schwarzenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin von Schwarzenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin von Schwarzenberg. The network helps show where Karin von Schwarzenberg may publish in the future.

Co-authorship network of co-authors of Karin von Schwarzenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Karin von Schwarzenberg. A scholar is included among the top collaborators of Karin von Schwarzenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin von Schwarzenberg. Karin von Schwarzenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwarzenberg, Karin von, et al.. (2023). A metabolic shift toward glycolysis enables cancer cells to maintain survival upon concomitant glutamine deprivation and V-ATPase inhibition. Frontiers in Nutrition. 10. 1124678–1124678. 7 indexed citations
2.
Schwarzenberg, Karin von, et al.. (2022). 572P High concordance of different molecular assays in the determination of HRD associated GIS in high grade epithelial ovarian cancer. Annals of Oncology. 33. S808–S809. 2 indexed citations
3.
Weichert, Wilko, Stephan Bartels, Gustavo Baretton, et al.. (2021). 758P Concordance between multiple HRD assays is substantial in high-grade ovarian cancer. Annals of Oncology. 32. S747–S747. 1 indexed citations
4.
Bartel, Karin, Helmut Pein, Bastian Popper, et al.. (2019). Connecting lysosomes and mitochondria – a novel role for lipid metabolism in cancer cell death. Cell Communication and Signaling. 17(1). 87–87. 34 indexed citations
5.
Bartel, Karin, Rolf Müller, & Karin von Schwarzenberg. (2019). Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells. Journal of Biological Chemistry. 294(46). 17239–17248. 9 indexed citations
6.
Ulrich, Melanie, et al.. (2016). MDM2 antagonist nutlin‐3a sensitizes tumors to V‐ATPase inhibition. Molecular Oncology. 10(7). 1054–1062. 16 indexed citations
7.
Bartel, Karin, Maria Winzi, Melanie Ulrich, et al.. (2016). V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy. Oncotarget. 8(6). 9476–9487. 36 indexed citations
8.
Schwarzenberg, Karin von, Thorsten Lehr, Melanie Ulrich, et al.. (2015). Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer. Cancer Research. 75(14). 2863–2874. 61 indexed citations
9.
Schwarzenberg, Karin von, Laura Schreiner, Rebekka Kubisch, et al.. (2014). V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer Cells. Molecular Cancer Therapeutics. 13(4). 926–937. 60 indexed citations
10.
Schwarzenberg, Karin von, et al.. (2013). V‐ATPase inhibition overcomes trastuzumab resistance in breast cancer. Molecular Oncology. 8(1). 9–19. 50 indexed citations
11.
Wiedmann, Romina M., Karin von Schwarzenberg, Andrea Palamidessi, et al.. (2012). The V-ATPase-Inhibitor Archazolid Abrogates Tumor Metastasis via Inhibition of Endocytic Activation of the Rho-GTPase Rac1. Cancer Research. 72(22). 5976–5987. 86 indexed citations
12.
Schwarzenberg, Karin von, Romina M. Wiedmann, Prajakta Oak, et al.. (2012). Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition. Journal of Biological Chemistry. 288(2). 1385–1396. 79 indexed citations
13.
Held, Stefanie Andrea Erika, Stefan Tenzer, Thomas Rückrich, et al.. (2012). Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides. Cancer Immunology Immunotherapy. 62(4). 715–726. 6 indexed citations
14.
Schwarzenberg, Karin von, et al.. (2011). Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation. Biochemical Pharmacology. 82(5). 453–463. 22 indexed citations
15.
Schwarzenberg, Karin von & Angelika M. Vollmar. (2010). Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy. Cancer Letters. 332(2). 295–303. 88 indexed citations
16.
Schwarzenberg, Karin von, et al.. (2009). Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone. Cellular and Molecular Life Sciences. 66(7). 1295–1308. 10 indexed citations
17.
Schmidt, Susanne M., Thomas König, Anita Bringmann, et al.. (2009). Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen. Leukemia. 23(10). 1818–1824. 10 indexed citations
18.
Brauer, Katharina M., Daniela Werth, Karin von Schwarzenberg, et al.. (2007). BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells. Cancer Research. 67(11). 5489–5497. 41 indexed citations
19.
Bringmann, Anita, Sebastian Schmidt, Markus M. Weck, et al.. (2007). Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia. 21(4). 732–738. 30 indexed citations
20.
Nencioni, Alessio, Anna Garuti, Karin von Schwarzenberg, et al.. (2006). Proteasome inhibitor‐induced apoptosis in human monocyte‐derived dendritic cells. European Journal of Immunology. 36(3). 681–689. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li-Yuan Bai Breakdown of academic impact, for papers by Carmen Aanei Breakdown of academic impact, for papers by Yuyin Li Breakdown of academic impact, for papers by Ayse Batova Breakdown of academic impact, for papers by Fusako Nishigaki Breakdown of academic impact, for papers by Shie-Pon Tzung Breakdown of academic impact, for papers by Xavier Billot Breakdown of academic impact, for papers by Randall Evans Breakdown of academic impact, for papers by Xianping Shi Breakdown of academic impact, for papers by Haolan Wang
Rankless by CCL
2026